Intraoperative artificial intelligence for brain tumor surgery: from tissue diagnosis to real-time surgical guidance
Surgeons can now learn tumor type and molecular features in real-time during brain surgery instead of waiting days, enabling better immediate surgical decisions.
This study validated an intraoperative AI that provides real-time molecular classification of gliomas including IDH status and methylation class during surgery, information that previously required days to weeks post-operatively. The advance directly enables intraoperative surgical decision-making aligned with WHO 2021 molecular glioma classification, representing a paradigm shift in neurosurgical oncology.
What the study was
- Study design
- Prospective clinical validation study
- Population
- Glioma patients undergoing surgical resection
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Neurosurgical focus
Why it surfaced
Real-time intraoperative molecular AI for glioma; transforms surgical oncology workflow by delivering actionable molecular information during rather than after surgery.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.